Cytel-led courses include two East training workshops in addition to new software demos, book signings and prizes at the Cytel booth #431.
Like the sound of 99% confidence in your trial's enrollment plan? Use Cyel's EnForeSys to compare competing enrollment strategies, accurately forecast milestones, and identify problem areas earlier.
Cytel and Amgen UK conducted a cross-company / academic exchange on innovative trial design advances and experiences: Bridging the gap between statistical theory and clinical reality.
--Simona Skerjanec, VP Medical Science
The Medicines Company
--Steven B. Ketchum, VP Research and Development
--Joe Heyes, VP
Early Stage Biostatistics Merck
--Dr. Scott Harris, CMO
--Dr. Patrice Rioux, VP, CMO
--Sylvain Nicolas, Global Head Biostatistics Phase 1 Studies